2022. The systemic factors of mitigating the contribution of the reversible phenotypic transitions of malignant cells to therapeutic resistance. Voprosy onkologii. 68, 6 (Dec. 2022), 708–716. DOI:https://doi.org/10.37469/0507-3758-2022-68-6-708-716.